DK3297611T3 - Farmaceutiske sammensætninger af levetiracetam med langvarig frigivelse - Google Patents

Farmaceutiske sammensætninger af levetiracetam med langvarig frigivelse Download PDF

Info

Publication number
DK3297611T3
DK3297611T3 DK16728462.9T DK16728462T DK3297611T3 DK 3297611 T3 DK3297611 T3 DK 3297611T3 DK 16728462 T DK16728462 T DK 16728462T DK 3297611 T3 DK3297611 T3 DK 3297611T3
Authority
DK
Denmark
Prior art keywords
levetiracetam
long
pharmaceutical compositions
term release
release
Prior art date
Application number
DK16728462.9T
Other languages
English (en)
Inventor
Michela Gallagher
Sharon Rosenzweig-Lipson
Elsie Melsopp
Jack Lawrence James
Original Assignee
Agenebio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agenebio Inc filed Critical Agenebio Inc
Priority claimed from PCT/US2016/033567 external-priority patent/WO2016191288A1/en
Application granted granted Critical
Publication of DK3297611T3 publication Critical patent/DK3297611T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK16728462.9T 2015-05-22 2016-05-20 Farmaceutiske sammensætninger af levetiracetam med langvarig frigivelse DK3297611T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562165812P 2015-05-22 2015-05-22
PCT/US2016/033567 WO2016191288A1 (en) 2015-05-22 2016-05-20 Extended release pharmaceutical compositions of levetiracetam

Publications (1)

Publication Number Publication Date
DK3297611T3 true DK3297611T3 (da) 2019-09-02

Family

ID=61223552

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16728462.9T DK3297611T3 (da) 2015-05-22 2016-05-20 Farmaceutiske sammensætninger af levetiracetam med langvarig frigivelse

Country Status (4)

Country Link
EP (2) EP3297611B1 (da)
DK (1) DK3297611T3 (da)
ES (1) ES2747993T3 (da)
MA (1) MA50634A (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL316051A (en) * 2022-04-01 2024-11-01 Agenebio Inc Methods for preventing or slowing the progression of cognitive decline or impairment in subjects displaying normal cognitive performance

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05005398A (es) 2002-11-22 2006-03-09 Univ Johns Hopkins Meta para terapia de deterioro cognitivo.
EP1924712B1 (en) 2005-08-03 2018-10-03 The Johns Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
US20080014271A1 (en) * 2006-07-13 2008-01-17 Ucb, S.A. Novel pharmaceutical compositions comprising levetiracetam
WO2008062446A2 (en) * 2006-09-14 2008-05-29 Alembic Limited An extended release composition of levetiracetam, which exhibits no adverse food effect
EP2346500B1 (en) * 2008-10-16 2017-05-17 The Johns Hopkins University Methods and compositions for improving cognitive function
KR20120055313A (ko) * 2010-11-23 2012-05-31 주식회사 바이오파마티스 레베티라세탐 또는 이의 약학적으로 허용되는 염을 포함하는 용출 안정성이 개선된 서방형 약학 조성물 및 이의 제조방법
DE102011103270A1 (de) * 2011-05-26 2012-11-29 Stada Arzneimittel Ag Pulverförmige Mischung zur Herstellung von Levetiracetam-haltigen Tabletten
CA2904767C (en) * 2013-03-15 2022-06-21 Agenebio, Inc. Methods and compositions for improving cognitive function

Also Published As

Publication number Publication date
ES2747993T3 (es) 2020-03-12
EP3297611A1 (en) 2018-03-28
EP3590506A1 (en) 2020-01-08
ES2747993T8 (es) 2021-03-30
MA50634A (fr) 2021-04-28
EP3297611B1 (en) 2019-07-03

Similar Documents

Publication Publication Date Title
DK3283107T3 (da) Sammensætninger omfattende en kombination af ipilimumab og nivolumab
EP3513809A4 (en) MEDICAL COMPOSITION
DK3509581T3 (da) Formuleringer af (r)-2-amino-3-phenylpropylcarbamat
DK3303317T3 (da) Fremgangsmåder og sammensætninger til inhibering af interaktionen af menin med MLL-proteiner
DK2968221T3 (da) Farmaceutisk sammensætning af s-ketaminhydrochlorid
DK3102555T3 (da) Sammensætninger af forbindelser og anvendelser deraf
DK3416996T3 (da) Hærdelig sammensætning
DK3144001T3 (da) Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf
EP3339331A4 (en) COMPOSITION
DK3079669T3 (da) Sammensætninger med forsinket frigivelse af linaclotid
EP3398996A4 (en) COMPOSITION
DK3393655T3 (da) Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme
DK3370949T3 (da) Sammensætning af tætningsmiddel
PT3261437T (pt) Compostos e composições fungicidas
DK3474822T3 (da) Formuleringer af brincidofovir
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3319609T3 (da) Sammensætninger og fremgangsmåder til anvendelse af antibakterielle lægemiddelkombinationer
DK3278801T3 (da) Farmaceutisk sammensætning indeholdende mirabegron
DK3368044T3 (da) Behandling af hepatisk steatose-relateret oligo-ovulation
EP3395887C0 (en) FLUOROR RUBBER COMPOSITION
DK3275452T3 (da) Farmaceutisk sammensætning med silibinin
DK3331498T3 (da) Nasalsammensætning
DK3322295T3 (da) Sammensætning
DK2910535T3 (da) Sammensætning til anvendelse af ekspanderet perlit
DK3297619T3 (da) Terapeutiske anvendelser af L-4-chlorkynurenin